Here are the latest stock price details of India's top Aluminium stocks. For more detailed updates, read our Aluminium sector report and check the latest Aluminium sector results.
Know More: Which way are the markets & the mutual fund industry headed?
SCRIP | BSE PRICE (Rs) | NSE PRICE (Rs) | CHART | MORE INFO |
---|---|---|---|---|
HINDALCO | 228.10 -1.40% | 227.90 -1.51% |
|
More Info ![]() |
NALCO | 46.25 -3.44% | 46.50 -2.92% |
|
More Info ![]() |
NIFTY 50 | Not Listed | 13,856.90 -0.79% |
|
More Info ![]() |
S&P BSE METAL | 11,240.41 -0.30% | Not Listed |
|
More Info ![]() |
S&P BSE SENSEX | 46,954.67 -0.96% | Not Listed |
|
More Info ![]() |
BSE prices: January 28, 2021 10:54:00 AM NSE prices: January 28, 2021 10:59:59 AM
Within the Aluminium sector, NALCO (down 3.4%) and HINDALCO (down 1.4%) are among the top losers.
Meanwhile, the benchmark S&P BSE SENSEX is at 46,954.7 (down 1.0%).
What else is happening in the markets today? Dig in...
Asian stock markets are trading lower today as a sudden sell-off on Wall Street and delays with coronavirus vaccines shook investor optimism about an early recovery for the global economy.
Here's an analysis of the annual report of NALCO for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of NALCO. Also includes updates on the valuation of NALCO.
Here's an analysis of the annual report of HINDALCO for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of HINDALCO. Also includes updates on the valuation of HINDALCO.
For the quarter ended December 2019, HINDALCO has posted a net profit of Rs 2 bn (down 22.0% YoY). Sales on the other hand came in at Rs 102 bn (down 14.3% YoY). Read on for a complete analysis of HINDALCO's quarterly results.
For the quarter ended December 2019, NALCO has posted a net profit of Rs 340 m (down 111.3% YoY). Sales on the other hand came in at Rs 21 bn (down 23.2% YoY). Read on for a complete analysis of NALCO's quarterly results.
More Views on NewsIn this video, I'll show you why it might be the right time to take money of the table in pharma stocks.
The pandemic failed to thwart Richa's investing success formula for 2020.
In this video, I'll show you a crucial chart that you need to check before you decide to sell any stock or index.
Our ace stock picker is ready to capitalise on a big growth opportunity.
More